Innova Captab (BOM:544067) Beneish M-Score: -1.99 (As of Jul. 01, 2026)


BOM:544067 Innova Captab Ltd BOM:544067
46 GF Score
Price ₹977.30
! 6 Warning Signs
View Full Analysis

What is Innova Captab Beneish M-Score?

Innova Captab BOM:544067 -1.82% 46 Beneish M-Score is -1.99 as of Jul. 01, 2026. GuruFocus rates BOM:544067 with a GF Score™ of 46/100. The stock has 6 warning signs investors should review. Among 908 Drug Manufacturers companies, Innova Captab ranks worse than 79.3% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -1.99 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Innova Captab's Beneish M-Score or its related term are showing as below:

BOM:544067' s Beneish M-Score Range Over the Past 10 Years
Min: -2.69   Med: -2.14   Max: -1.57
Current: -1.99

During the past 8 years, the highest Beneish M-Score of Innova Captab was -1.57. The lowest was -2.69. And the median was -2.14.


Innova Captab Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Innova Captab's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innova Captab Beneish M-Score Chart

Innova Captab Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beneish M-Score
Get a 7-Day Free Trial -1.57 -2.03 -2.69 -2.24 -1.99

Innova Captab Quarterly Data
Mar19 Mar20 Mar21 Dec21 Mar22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.24 0.00 0.00 0.00 -1.99

BOM:544067 vs ZTS, UTHR: Beneish M-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Innova Captab's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Innova Captab Beneish M-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Innova Captab's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Innova Captab's Beneish M-Score falls into.


BOM:544067
46GF Score
Innova Captab Ltd BOM:544067
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Innova Captab Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Innova Captab for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.1124+0.528 * 0.985+0.404 * 1.3938+0.892 * 1.2993+0.115 * 0.5697
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.2039+4.679 * 0.013281-0.327 * 1.022
=-1.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was ₹5,208 Mil.
Revenue was ₹16,039 Mil.
Gross Profit was ₹5,229 Mil.
Total Current Assets was ₹9,230 Mil.
Total Assets was ₹18,374 Mil.
Property, Plant and Equipment(Net PPE) was ₹8,513 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹452 Mil.
Selling, General, & Admin. Expense(SGA) was ₹369 Mil.
Total Current Liabilities was ₹4,946 Mil.
Long-Term Debt & Capital Lease Obligation was ₹2,158 Mil.
Net Income was ₹1,409 Mil.
Gross Profit was ₹0 Mil.
Cash Flow from Operations was ₹1,165 Mil.
Total Receivables was ₹3,603 Mil.
Revenue was ₹12,344 Mil.
Gross Profit was ₹3,964 Mil.
Total Current Assets was ₹7,031 Mil.
Total Assets was ₹15,804 Mil.
Property, Plant and Equipment(Net PPE) was ₹8,384 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹248 Mil.
Selling, General, & Admin. Expense(SGA) was ₹236 Mil.
Total Current Liabilities was ₹3,530 Mil.
Long-Term Debt & Capital Lease Obligation was ₹2,449 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(5208.29 / 16039.07) / (3603.46 / 12344.23)
=0.324725 / 0.291915
=1.1124

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(3963.86 / 12344.23) / (5228.77 / 16039.07)
=0.32111 / 0.326002
=0.985

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (9229.61 + 8513.18) / 18373.79) / (1 - (7031.14 + 8383.53) / 15804.07)
=0.034342 / 0.024639
=1.3938

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=16039.07 / 12344.23
=1.2993

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(247.79 / (247.79 + 8383.53)) / (451.79 / (451.79 + 8513.18))
=0.028708 / 0.050395
=0.5697

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(369.03 / 16039.07) / (235.92 / 12344.23)
=0.023008 / 0.019112
=1.2039

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((2158.23 + 4945.82) / 18373.79) / ((2448.94 + 3530.04) / 15804.07)
=0.38664 / 0.378319
=1.022

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(1409.17 - 0 - 1165.15) / 18373.79
=0.013281

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Innova Captab has a M-score of -1.99 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -1.99 mean?
Innova Captab (BOM:544067) has a Beneish M-Score of -1.99 as of Jul. 01, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Innova Captab and its competitors. According to the industry distribution chart, Innova Captab ranks #720 out of 908 companies in the Drug Manufacturers industry, placing it in the top 79.3%.
Is Innova Captab's Beneish M-Score too high?
Innova Captab's current Beneish M-Score is -1.99. Based on the distribution chart, Innova Captab ranks #720 out of 908 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Innova Captab has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.
How does Innova Captab's Beneish M-Score compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Innova Captab ranks #720 out of 908 companies for Beneish M-Score. This places Innova Captab in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Drug Manufacturers company?
A good Beneish M-Score depends on the Drug Manufacturers industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Innova Captab and its competitors. Innova Captab's current Beneish M-Score is -1.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innova Captab stock overvalued right now?
Innova Captab (BOM:544067) has a current Beneish M-Score of -1.99. The current Beneish M-Score is -1.99. Innova Captab's overall GF Score™ is 46/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Innova Captab (BOM:544067), the current Beneish M-Score is -1.99 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innova Captab Business Description

Other Exchanges INNOVACAP:India
Address Plot No.320, Industrial Area, Phase-1, Panchkula, HR, IND, 134113
Innova Captab Ltd is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The Company has identified "Drugs and pharmaceutical products" as single operating segment. The company has presence in India, and Outside India. The company generates majority of revenue from India. The company's products are Cephalosporins, Proton Pump Inhibitor, Antocholinergic and Heparin NSAIDs, Analgesics and Antipyretic, Anticold and Antiallergic, Antiemetic, Antidiabetic, Antispasmodic, Antifibrinolytic, Cardiovascular, Antioxidant and Vitamins, Antihyperuricemia and Antigout, Fluoroquinolone and Macrolide, Nootropics and Neurotonics/ Neurotrophics, Antiulcerative, Antimalarial Anxiolytic, Anticonvulsant and Antipsychotic, Bladder and Prostate Disorder, etc.
46GF Score

Get the complete analysis for BOM:544067

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹977.30
Price